| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |